IR Iran
Research Article
Synthesis, Biological Evaluation and Molecular Modeling of (E)-
3-Propargylene-1, 3-Dihydro-2H-Indol-2-Ones as Acetyl- and
Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease
Author(s): Ying Dong, Xiao Ming Zha, Xue Ping Chu, Di Kang, Su Lan Luo, Tao Lu and Qing Fa ZhouYing Dong, Xiao Ming Zha, Xue Ping Chu, Di Kang, Su Lan Luo, Tao Lu and Qing Fa Zhou
The synthesis, pharmacological evaluation and molecular modeling of (E)-3-propargylene-1,3-dihydro-2Hindol- 2-ones, targeting both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), are described. In vitro inhibition experiments of AChE and BuChE showed that compound 2, 5 and 12 are able to inhibit the two forms of cholinesterases in the submicromolar range. The most selective inhibitor of EeAChE (acetylcholinesterase, E.C. 3.1.1.7, from Electrophorus electricus) and eqBuChE (butylcholinesterase, E.C. 3.1.1.8, from equine serum) in this series are compound 9 (IC50=0.011 ± 0.018 μM) and compound 14 (IC50=0.12 ± 0.22 μM) respectively. But the substitution at 5- or 6- position of indolones is not generally favored for eqBuChE inhibition. Kinetic studies of the BuChE inhibition suggested that compound 1 and 5 produce a mixe.. Read More»
DOI:
10.4172/2161-0444.1000372
Medicinal Chemistry received 6627 citations as per Google Scholar report